Shares of Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $20.18 and last traded at $20.18, with a volume of 130 shares trading hands. The stock had previously closed at $20.5920.
Hikma Pharmaceuticals Trading Down 0.5%
The business has a fifty day moving average price of $22.68 and a two-hundred day moving average price of $25.24. The company has a current ratio of 1.24, a quick ratio of 0.72 and a debt-to-equity ratio of 0.33.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Dividend Payout Ratio Calculator
- Cloudflare Just Broke the Internet, But It’s Still a Red-Hot Buy
- What Investors Need to Know About Upcoming IPOs
- Anthropic Just Became AI’s Hottest Ticket—Backed by Microsoft and NVIDIA
- The 3 Best Fintech Stocks to Buy Now
- Affirm Just Crushed Earnings—But Can It Outrun Klarna’s Scale?
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
